| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/08/2000 | WO2000023592B1 Minimal promoters and uses thereof |
| 09/08/2000 | WO2000023573A3 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 09/08/2000 | CA2364463A1 Introducing a biological material into a patient |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2364279A1 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 09/08/2000 | CA2363488A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 09/08/2000 | CA2362995A1 Anti-neoplastic compositions and uses thereof |
| 09/06/2000 | EP1032696A1 Vector for tissue-specific replication and gene expression |
| 09/06/2000 | EP1032675A1 Attaching substances to micro-organisms |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032651A1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 09/06/2000 | EP1032418A1 Compact epstein-barr virus replicons |
| 09/06/2000 | EP1032413A1 Chemoprotective bacterial strains |
| 09/06/2000 | EP1032407A1 Use of putamen ovi |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032382A1 Anti-obesity agent |
| 09/06/2000 | EP1032271A1 Purging of stem cell products |
| 09/06/2000 | EP1032269A1 Treatment of neoplasms with viruses |
| 09/06/2000 | EP1032268A1 Reduced antigenic cells and uses therefor |
| 09/06/2000 | EP1032265A1 New psoralens for pathogen inactivation |
| 09/06/2000 | EP0915906B1 Methods for the selective separation of organic components from biological fluids |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265599A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 09/06/2000 | CN1265597A Composition comprising propolis and at least an essential oil |
| 09/06/2000 | CN1265596A Isoflavone-containing compositions |
| 09/06/2000 | CN1265564A Method for administering viable microorganism composition for poultry |
| 09/06/2000 | CN1265319A Medicine for dredging the meridian passage and softening mass and its preparation |
| 09/06/2000 | CN1265317A Hantongling capsule for treatment of wind-cold and wind-dampness syndrome |
| 09/06/2000 | CN1265316A Kidney-invigorating and bone strengthening capsule |
| 09/06/2000 | CN1265314A Liver-invigorating detoxication pill for treating hepatitis B |
| 09/06/2000 | CN1265313A Dermatosis treating medicine |
| 09/06/2000 | CN1265312A Psoriasis treating medicine |
| 09/06/2000 | CN1265309A Medicine for rheumatism and aploplexy and its preparation |
| 09/06/2000 | CN1056184C Lumbricus wine and its producing method |
| 09/06/2000 | CN1056081C Medicine for curing severe bone flourosis and production method thereof |
| 09/06/2000 | CN1056074C Tengxiling fumigant |
| 09/06/2000 | CN1056073C Nutritious health-care oral liquor |
| 09/06/2000 | CN1056072C Vaginal cleaning powder |
| 09/06/2000 | CN1056071C Hepatitis virus inhibitor and prepn. method thereof |
| 09/06/2000 | CN1056067C Wuji (black-bone chicken) tonic liquid |
| 09/06/2000 | CN1056064C Medicine for curing liver cancer and its making method |
| 09/06/2000 | CN1056063C Method for extracting marine shellfish active matter clam extracted from clam meat |
| 09/06/2000 | CN1056062C Instant deerhorn powder and prep. thereof |
| 09/06/2000 | CN1056061C Medicine for treating self-biting disease for fox and preparing process thereof |
| 09/05/2000 | US6114599 Producing glucose regulated insulin producing cells whose proliferation is regulated by tetracycline; introducing into cells a tetracycline fusion protein gene, an insulin promoter and a gene encoding an sv40 antigen and tetracycline promoter |
| 09/05/2000 | US6114504 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6114336 Cosmetic composition containing a neuropeptide Y receptor antagonist |
| 09/05/2000 | US6114311 Administering an adenviral compound |
| 09/05/2000 | US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying |
| 09/05/2000 | US6114108 Methods and compositions for the selective modification of viral nucleic acids |
| 09/05/2000 | US6113951 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6113932 Nontoxic vernix compositions and method of producing |
| 09/05/2000 | US6113913 Genomes and gene codes |
| 09/05/2000 | US6113912 Hepatitis A virus vaccines |
| 09/05/2000 | US6113907 Pharmaceutical grade St. John's Wort |
| 09/05/2000 | US6113902 Polypeptides with amino acid sequences of pro-lys-ile and cyclic epitopes |
| 09/05/2000 | CA2116442C Novel glycosphingolipids and the use thereof |
| 09/05/2000 | CA2047685C Purified insulin mediators and purification process for same |
| 08/31/2000 | WO2000050570A2 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells |
| 08/31/2000 | WO2000050569A1 Method of modifying cytotoxic cells and uses thereof |
| 08/31/2000 | WO2000050568A2 Transplantation of haematopoietic cells |
| 08/31/2000 | WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | WO2000050072A2 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 08/31/2000 | WO2000050051A2 Reovirus for the treatment of cellular proliferative disorders |
| 08/31/2000 | WO2000050049A2 Artificial salivary gland |
| 08/31/2000 | WO2000050048A2 Bone marrow transplantation for hepatic regeneration and repair |
| 08/31/2000 | WO2000050047A2 Composition for the treatment of psoriasis |
| 08/31/2000 | WO2000049892A2 Dietetic supplement from human placenta |
| 08/31/2000 | WO2000029003A3 Method for preventing and reversing atherosclerosis in mammals |
| 08/31/2000 | WO2000028038A3 Virulence genes and proteins, and their use |
| 08/31/2000 | WO2000027410A3 Composition and method for increasing weight gain and feed efficiency |
| 08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 08/31/2000 | CA2710788A1 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 08/31/2000 | CA2615684A1 Reovirus for the treatment of cellular proliferative disorders |
| 08/31/2000 | CA2363621A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | CA2363036A1 Composition for the treatment of psoriasis |
| 08/31/2000 | CA2361401A1 Transplantation of haematopoietic cells |
| 08/31/2000 | CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/30/2000 | EP1030929A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 08/30/2000 | EP1030928A1 Development of viruses resistant to inactivation by the human complement system |
| 08/30/2000 | EP1030908A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 08/30/2000 | EP1030697A2 Biodegradable polymer scaffold |
| 08/30/2000 | EP1030690A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 08/30/2000 | EP1030677A1 Synergetic oral composition combining sulphuric chondroitin acid and/or dna with hydroxyproline |
| 08/30/2000 | EP1030676A1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 08/30/2000 | EP1030675A2 Treatment of hematologic disorders |
| 08/30/2000 | EP1030674A1 METHODS FOR TREATMENT OF TUMORS AND TUMOR CELLS USING $i(EX VIVO) ACTIVATED T CELLS |
| 08/30/2000 | EP0837692B1 Clostridium difficile toxins and toxoids as mucosal adjuvants |
| 08/30/2000 | EP0668772B1 Specific immune system modulation |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | EP0527199B2 Compositions for use in a method for treating a human suffering from multiple sclerosis |
| 08/30/2000 | CN2393540Y Active healthy water generator |
| 08/30/2000 | CN1265141A Use of lactobacillus for reduction of fibrinogen level in blood |
| 08/30/2000 | CN1265038A Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 08/30/2000 | CN1265036A Anti-coagulation of blood, blood plasma or synovial fluid products |
| 08/30/2000 | CN1264594A Labor-inducing oral liquid and preparing process thereof |
| 08/30/2000 | CN1264593A Medicine for treating dermatopathy and preparing process thereof |
| 08/30/2000 | CN1264592A Medicine for treating ichthyosis and preparing process thereof |
| 08/30/2000 | CN1264587A Medicine for treating gastroenteropathy |